TP53 and ovarian carcinoma: Additionally, SMYD3 is frequently overexpressed in epithelial ovarian cancer and promotes metastasis by directly decreasing p53 protein stability and promoting p53 ubiquitination, indicating that SMYD3 may be a novel E3 ligase of p5382.